Use of pentoxifyllin in the treatment of multiple sclerosis

Details Use of pentoxifyllin in the treatment of multiple sclerosis Use of pentoxifyllin in the treatment of multiple sclerosis

A - Human Necessities

61

K

A61K 31/52 (2006.01) A61K 31/56 (2006.01) A61K 31/57 (2006.01)

Patent

CA 2176848

The present invention relates to the use of pentoxy- phylline in treating both intermittently or chronically progressing forms of multiple sclerosis. It can be used either alone or in combination with corticosteroids. Irrespective of whether corticosteroids are present, the dosage is 0.01 to 6.0 g/day.

L'invention concerne l'utilisation de la pentoxyfylline dans le traitement de la sclérose en plaques évoluant par poussées successives ou progressivement de manière chronique. Cette substance peut s'utiliser seule ou en combinaison avec des corticostéroïdes, à raison de 0,01 à 6,0 g/jour, indépendamment de l'éventuelle présence de corticostéroïdes.

Affiliated with

Also associated with

Rating

Use of pentoxifyllin in the treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of pentoxifyllin in the treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of pentoxifyllin in the treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1363658